Value and payment for oncology in the United States;Valeur et paiement des médicaments innovants: Cas de l'oncologie aux États-Unis

Annales Pharmaceutiques Francaises

Volumn 71, Issue 5, 2013, Pages 285-290

  Robinson, J C ^a  

^a School of Public Health   (United States)

Author keywords

Care management; Episode of care; Medicine; Oncology; Payment; Performance; Price; USA

Indexed keywords

ARTICLE; DRUG COST; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HOSPITAL PURCHASING; HUMAN; ONCOLOGIST; ONCOLOGY; PATIENT CARE; PROFIT; REIMBURSEMENT; UNITED STATES;

CARE MANAGEMENT; EPISODE OF CARE; ÉPISODE DE SOINS; ÉTATS-UNIS; MANAGEMENT DES SOINS; MEDICINE; MÉDICAMENTS; ONCOLOGIE; ONCOLOGY; PAIEMENT; PAYMENT; PERFORMANCE; PRICE; PRIX; USA;

ANTINEOPLASTIC AGENTS; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; REIMBURSEMENT MECHANISMS; RESEARCH; UNITED STATES;

EID: 84884977696     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2013.08.003     Document Type: Article

References (11)

1. Bach P.B. Limits on medicare's ability to control rising spending on cancer drugs. N Engl J Med 2009, 360(6):626-633.
2. Jacobson M., O'Malley A.J., Earle C.C., Pakes J., Gaccione P., Newhouse J.P. Does reimbursement influence chemotherapy treatment for cancer patients?. Health Aff 2006, 25(2):437-443.
3. Cotter D., Thamer M., Narasimhan K., Zhang Y., Bullock K. Translating epoetin research into practice: the role of government and the use of scientific evidence. Health Aff 2006, 25(5):1249-1259.
4. Bach P.B., Mirkin J.N., Luke J.L. Episode-based payment for cancer care. Health Aff 2011, 30(3):500-509.
5. Fitch K., Pyenson B. Site of service cost differences for medicare patients receiving chemotherapy 2011, Milliman, New York, [http://publications.milliman.com/publications/health-published/pdfs/sit e-of-service-cost-differences.pdf contrÔlé juillet 2013].
6. Conti R.M., Bach P.B. Cost consequences of the 340B drug discount program. JAMA 2013, 309(19):1995-1996.
7. Miller H. From volume to value: better ways to pay for health care. Health Aff 2009, 28(5):1418-1428.
8. Newcomer L.N. Changing physician incentives for cancer care to reward better patient outcomes instead of use of more costly drugs. Health Aff 2012, 31(4):780-785.
9. Johnson A. In treating cancer, insurer tries new way to pay docs. Wall Street Journal 2010, 20.
10. Bosserman L.D., Verrilli D., McNatt W. Partnering with a payer to develop a value-based medical home pilot. Am J Manag Care 2012, 18(SP4):1-3.
11. Megerlin F, Lopert R, Taymor K, Trouvin JH. Biosimilars and the European experience: implications for the United States. Health Aff 2013 [accepted].